Remote Patient Monitoring for Heart Failure

(FAST-RPM-HF Trial)

Recruiting in Palo Alto (17 mi)

+3 other locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Saint Luke's Health System

No Placebo Group

Approved in 3 Jurisdictions

Trial Summary

What is the purpose of this trial?

Previous research has investigated the use of remote patient monitoring in various clinical contexts, however there has not been a clinical trial examining use of the VitalCare platform for ambulatory management of heart failure. This trial will serve as a pilot study examining the feasibility of use of the VitalCare platform for ambulatory heart failure management and examine the effect of remote patient monitoring on patient engagement. To the investigators' knowledge, this will be the first study examining the effect of remote patient monitoring with the VitalCare platform on heart failure clinical outcomes, such as hospitalization for heart failure exacerbations and emergency room visits for heart failure.

Eligibility Criteria

This trial is for adults with heart failure who've been hospitalized for it within the last year, can use a smartphone or tablet, and speak English. It's not for pregnant individuals, those awaiting a heart transplant, with severe kidney disease or very poor heart function (LVEF < 35%), or have certain implanted cardiac devices.

Inclusion Criteria

I have moderate heart failure symptoms.

Own a smartphone or tablet or comfortable with using one

I have been diagnosed with heart failure.

Exclusion Criteria

You are waiting for a heart transplant.

My heart failure symptoms are mild or very severe.

My kidneys are in the final stage of failure.

Treatment Details

Interventions

• Remote Patient Monitoring (VitalCare Platform)

Trial Overview The study tests the VitalCare platform's ability to monitor heart failure patients remotely. It aims to see if this technology improves patient engagement and reduces hospital visits due to worsening heart failure.

Participant Groups

Group I: Interventional Experimental Treatment 1 Intervention

All patients receive the VitalCare platform with a tablet computer, an Eko Duo device, a weight scale, a blood pressure cuff, a pulse oximeter

Remote Patient Monitoring is already approved in United States, European Union, Canada for the following indications:

🇺🇸 Approved in United States as Remote Patient Monitoring for:

• Chronic conditions such as hypertension, diabetes, asthma, COPD, congestive heart failure, and chronic kidney disease

🇪🇺 Approved in European Union as Remote Patient Monitoring for:

• Cardiovascular diseases, diabetes, asthma, COPD, and chronic kidney disease

🇨🇦 Approved in Canada as Remote Patient Monitoring for:

• Chronic conditions such as hypertension, diabetes, asthma, COPD, and chronic kidney disease

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Saint Luke's Hospital of Kansas City Kansas City, KS

Saint Luke's East Hospital Lee's Summit, MO

Saint Luke's South Hospital Overland Park, KS

Saint Luke's North Hospital Kansas City, MO

Who Is Running the Clinical Trial?

Saint Luke's Health System Lead Sponsor

References